- All sections
- C - Chemistry; metallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/24 - Esteramides
Patent holdings for IPC class C07F 9/24
Total number of patents in this class: 362
10-year publication summary
|
32
|
29
|
33
|
33
|
26
|
17
|
22
|
29
|
21
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 1949 |
20 |
| Cancer Targeted Technology LLC | 25 |
13 |
| Sony Group Corporation | 12522 |
10 |
| Sony Corporation | 31580 |
7 |
| Suzhou Abogen Biosciences Co., Ltd. | 65 |
7 |
| Medivir AB | 143 |
6 |
| F. Hoffmann-La Roche AG | 7942 |
5 |
| The Johns Hopkins University | 5519 |
5 |
| Central Glass Company, Limited | 1241 |
5 |
| UPL Limited | 549 |
5 |
| LG Chem, Ltd. | 17620 |
4 |
| Sony Corporation of America | 343 |
4 |
| Centre National de La Recherche Scientifique | 10052 |
4 |
| Chemapotheca, LLC | 13 |
4 |
| Quiapeg Pharmaceuticals AB | 47 |
4 |
| Universite de Bretagne Occidentale | 110 |
4 |
| Washington State University | 464 |
4 |
| Eisai R&D Management Co., Ltd. | 1271 |
4 |
| Arysta LifeScience Inc. | 69 |
4 |
| Janssen Biopharma, Inc. | 49 |
4 |
| Other owners | 239 |